Gilead Sciences GILD
NASDAQ GILD
$143.72 -1.09 (-0.75%)
As of: Sep 11, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026)

Gilead Sciences' (GILD) quarterly Dividends Paid - Common came in at $1.0 billion in Q2 2026, up 3.41% on a YoY basis from $997.0 million in Q2 2025, and down 0.87% quarter-over-quarter from $1.0 billion in Q1 2026.

Analysis

Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Dividends Paid - Common for 13 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Dividends Paid - Common rose 3.41% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $4.1 billion (up 2.6% YoY), and the FY2025 full-year result was $4.0 billion, up 2.17% from the prior year.
  • Dividends Paid - Common slipped to $1.0 billion in Q2 2026 per GILD's latest filing, from $1.0 billion in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.0 billion in Q1 2026 and bottomed at $928.0 million in Q4 2022.
  • Historically, Dividends Paid - Common has averaged $974.8 million across 5 years, with a median of $975.0 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Dividends Paid - Common advanced 1.84% in 2025, then gained 3.41% in 2026.
  • Over 5 years, Dividends Paid - Common stood at $928.0 million in 2022, then advanced by 2.16% to $948.0 million in 2023, then advanced by 2.64% to $973.0 million in 2024, then increased by 2.16% to $994.0 million in 2025, then rose by 3.72% to $1.0 billion in 2026.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered $1.0 billion, $1.0 billion, and $994.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.36 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 1.03 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 96.80 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Bn
Mar 31, 2026 1.04 Bn
Dec 31, 2025 994.00 Mn
Sep 30, 2025 995.00 Mn
Jun 30, 2025 997.00 Mn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 973.00 Mn
Sep 30, 2024 977.00 Mn
Jun 30, 2024 978.00 Mn
Mar 31, 2024 990.00 Mn
Dec 31, 2023 948.00 Mn
Sep 30, 2023 953.00 Mn
Jun 30, 2023 954.00 Mn
Mar 31, 2023 969.00 Mn
Dec 31, 2022 928.00 Mn
Sep 30, 2022 933.00 Mn
Jun 30, 2022 932.00 Mn
Mar 31, 2022 945.00 Mn
Dec 31, 2021 904.00 Mn
Sep 30, 2021 905.00 Mn